Soohee Cho
No Rating Available
(Learn About Our Rating System)

Soohee Cho, MD, MSCS

Languages spoken: English

Clinical Locations

Primary Location

Primary Children's Hospital

Cancer Blood and Marrow Clinic
100 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-662-4700
Get Directions

Dr. Cho is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Pediatric Bone Marrow Transplant and Immunology Team at the University of Utah and Primary Children’s Hospital. He received his medical degree from Emory University, where he also completed his residency.

Dr. Cho pursued his Pediatric Hematology and Oncology Fellowship at the University of Colorado School of Medicine, where he also received his master's degree in Clinical Science. He went on to complete his advanced fellowship in Pediatric Bone Marrow Transplant at the University of California, San Francisco School of Medicine.

Dr. Cho is board-certified in Pediatrics and Pediatric Hematology and Oncology. Dr. Cho’s clinical interests include the treatment of high risk acute myeloid leukemia and other rare myeloid malignancies requiring bone marrow transplant. He has an emphasis on individualized chemotherapy dosing and cellular manufacturing designed to reduce toxicity in patients with relapsed and refractory disease, as well as supportive care in children receiving bone marrow transplants and cellular/immunotherapy products.

Specialties

Board Certification

American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Dr. Cho is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Pediatric Bone Marrow Transplant and Immunology Team at the University of Utah and Primary Children’s Hospital. He received his medical degree from Emory University, where he also completed his residency.

Dr. Cho pursued his Pediatric Hematology and Oncology Fellowship at the University of Colorado School of Medicine, where he also received his master's degree in Clinical Science. He went on to complete his advanced fellowship in Pediatric Bone Marrow Transplant at the University of California, San Francisco School of Medicine.

Dr. Cho is board-certified in Pediatrics and Pediatric Hematology and Oncology. Dr. Cho’s clinical interests include the treatment of high risk acute myeloid leukemia and other rare myeloid malignancies requiring bone marrow transplant. He has an emphasis on individualized chemotherapy dosing and cellular manufacturing designed to reduce toxicity in patients with relapsed and refractory disease, as well as supportive care in children receiving bone marrow transplants and cellular/immunotherapy products.

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Academic Divisions Hematology/Oncology
Board Certification
American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)
American Board of Pediatrics (Pediatrics)

Education history

Undergraduate Biochemistry - Georgia Institute of Technology B.S.
Professional Medical Medicine - Emory University School of Medicine M.D.
Residency General Pediatrics - Emory University School of Medicine Resident
Fellowship Pediatric Hematology/Oncology - University of Colorado School of Medicine Fellow
Graduate Training Clinical Science - University of Colorado School of Medicine MSCS
Fellowship Pediatric Bone Marrow Transplant - University of California, San Francisco School of Medicine Fellow

Selected Publications

Journal Article

  1. Cho S, Vigers T, Pyle L, Franklin A, Sopfe J, Jeney F, Forlenza G (2023). Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes Technol Ther, 25(2), 116-121.
  2. Eckard AR, Cho S, O'Riordan MA, McComsey GA (2017). Kallistatin levels in HIV-infected patients and effects of statin therapy. Biomarkers, 22(1), 55-62.
  3. Vegh RB, Solntsev KM, Kuimova MK, Cho S, Liang Y, Loo BL, Tolbert LM, Bommarius AS (2011). Reactive oxygen species in photochemistry of the red fluorescent protein "Killer Red". Chem Commun (Camb), 47(17), 4887-9.
  4. Dvorak CC, Cho S, Salinas Cisneros G, Higham CS, Chu J, Winestone LE, Temple WC, Kharbanda S, Shimano KA, Avagyan S, Pauerstein PT, Huang JN, Cheng G, Lalefar N, Aguayo-Hiraldo P, Keizer RJ, Pulsipher MA, Long-Boyle J (2025). High Melphalan Exposure Increases the Risk of Graft-Versus-Host Disease in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation. Transplantation and cellular therapy, 31(6), 384.e1-384.e15.
  5. Dvorak CC, Long-Boyle JR, Holbrook-Brown L, Abdel-Azim H, Bertaina A, Vatsayan A, Talano JA, Bunin N, Anderson E, Flower A, Lalefar N, Higham CS, Kapoor N, Klein O, Odinakachukwu MC, Cho S, Jacobsohn DA, Collier W, Pulsipher M (2024). Effect of rabbit ATG PK on outcomes after TCR-¿ß/CD19-depleted pediatric haploidentical HCT for hematologic malignancy. Blood advances, 8(23), 6003-6014.
  6. Harding E, Cho S, Garrington T, Mandell (2023). A Neonate Presenting with Cholestasis and Thrombocytopenia. NeoReviews, 24(9), e583-e586.

Book Chapter

  1. Michael A. Pulsipher, Soohee Cho, Muna Qayed, and Brigitte Strah (2025). Pizzo & Poplack's Principles and Practice of Pediatric Oncology, 9th Edition, Chapter 13, General Principles of Hematopoietic Stem Cell Transplantation.

Abstract

  1. Jost E, Cho S, Lange S, Berget C, Pinsker JE, Hartman L, and Forlenza GP (2024). 967-P: The Use of Hybrid Closed-Loop Insulin Delivery in Adolescents and Young Adults with High-Risk Acute Lymphoblastic Leukemia during Induction Chemotherapy. 73(Supplement_1), 967-P.